UNITEDHEALTH GROUP

UNH
Real-time Estimate Quote. Real-time Estimate  - 12/01 07:04:54 am
448.56USD +0.98%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 332 732418 389
Entreprise Value (EV)1 359 278440 185
P/E ratio 21,9x24,8x
Yield 1,38%1,21%
Capitalization / Revenue 1,29x1,46x
EV / Revenue 1,40x1,54x
EV / EBITDA 14,2x16,3x
Price to Book 5,10x5,60x
Nbr of stocks (in thousands) 948 821941 851
Reference price (USD) 351444
Announcement Date 01/20/2021-
Previous period Next period
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 257 141286 123
EBITDA1 25 29626 954
Operating profit (EBIT)1 22 40523 979
Operating Margin 8,71%8,38%
Pre-Tax Profit (EBT)1 20 74222 224
Net income1 15 40317 109
Net margin 5,99%5,98%
EPS2 16,017,9
Dividend per Share2 4,835,38
Announcement Date 01/20/2021-
Previous period Next period
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 26 54621 796
Net Cash position1 --
Leverage (Debt / EBITDA) 1,05x0,81x
Free Cash Flow1 20 12319 939
ROE (Net Profit / Equities) 24,9%24,3%
Shareholders' equity1 61 85970 519
ROA (Net Profit / Asset) 8,30%8,51%
Assets1 185 589200 968
Book Value Per Share2 68,879,4
Cash Flow per Share2 23,125,0
Capex1 2 0512 375
Capex / Sales 0,80%0,83%
Announcement Date 01/20/2021-
Previous period Next period
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 418 389 M $ -
Entreprise Value (EV) 440 185 M $ 431 159 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) 24,8x 21,6x
Capitalization / Revenue 1,46x 1,34x
EV / Revenue 1,54x 1,41x
EV / EBITDA 16,3x 14,5x
Yield (DPS / Price) 1,21% 1,33%
Price to book (Price / BVPS) 5,60x 4,95x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 8,38% 8,72%
Operating Leverage (Delta EBIT / Delta Sales) 0,62x 1,47x
Net Margin (Net Profit / Revenue) 5,98% 6,25%
ROA (Net Profit / Asset) 8,51% 9,02%
ROE (Net Profit / Equities) 24,3% 25,2%
Rate of Dividend 30,1% 28,8%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   0,83% 0,83%
Cash Flow / Sales 8,24% 7,86%
Capital Intensity (Assets / Sales) 0,70x 0,69x
Financial Leverage (Net Debt / EBITDA) 0,81x 0,42x
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend